TP53-dependent genomic instability

被引:3
|
作者
Danovi, Safia
机构
[1] Nature Genetics,
关键词
D O I
10.1038/s41588-022-01216-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:1584 / 1584
页数:1
相关论文
共 50 条
  • [41] TELOMERE DNA CONTENT AND TP53 STATE PROVIDE AN INSIGHT INTO GENOMIC INSTABILITY IN OLDER ADULT PATIENTS WITH ALL
    Zakout, G.
    Rai-Shetty, L.
    Moorman, A. V.
    Fielding, A. K.
    HAEMATOLOGICA, 2014, 99 : 6 - 6
  • [42] Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis
    Valgardsdottir, R
    Tryggvadottir, L
    Steinarsdottir, M
    Olafsdottir, K
    Jonasdottir, S
    Jonasson, JG
    Ogmundsdottir, HM
    Eyfjord, JE
    APMIS, 1997, 105 (02) : 121 - 130
  • [43] TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer
    Zhang, Meiying
    Zhuang, Guanglei
    Sun, Xiangjun
    Shen, Yanying
    Wang, Wenjing
    Li, Qing
    Di, Wen
    DIAGNOSTIC PATHOLOGY, 2017, 12
  • [44] Genomic landscape of TP53-mutated myeloid malignancies
    Abel, Haley J.
    Oetjen, Karolyn A.
    Miller, Christopher A.
    Ramakrishnan, Sai M.
    Day, Ryan B.
    Helton, Nichole M.
    Fronick, Catrina C.
    Fulton, Robert S.
    Heath, Sharon E.
    Tarnawsky, Stefan P.
    Srivatsan, Sridhar Nonavinkere
    Duncavage, Eric J.
    Schroeder, Molly C.
    Payton, Jacqueline E.
    Spencer, David H.
    Walter, Matthew J.
    Westervelt, Peter
    Dipersio, John F.
    Ley, Timothy J.
    Link, Daniel C.
    BLOOD ADVANCES, 2023, 7 (16) : 4586 - 4598
  • [45] Tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia
    Tao, Yan-Fang
    Li, Zhi-Heng
    Wang, Na-Na
    Fang, Fang
    Xu, Li-Xiao
    Pan, Jian
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2931 - 2944
  • [46] 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers
    Yang, Hailing
    Shu, Zhang
    Jiang, Yongying
    Mao, Weiqun
    Pang, Lan
    Redwood, Abena
    Jeter-Jones, Sabrina L.
    Jennings, Nicholas B.
    Ornelas, Argentina
    Zhou, Jinhua
    Rodriguez-Aguayo, Cristian
    Bartholomeusz, Geoffrey
    Iles, LaKesla R.
    Zacharias, Niki M.
    Millward, Steven W.
    Lopez-Berestein, Gabriel
    Le, Xiao-Feng
    Ahmed, Ahmed A.
    Piwnica-Worms, Helen
    Sood, Anil K.
    Bast, Robert C.
    Lu, Zhen
    CLINICAL CANCER RESEARCH, 2019, 25 (18) : 5702 - 5716
  • [47] Reprimo, a potential tumor suppressor gene TP53-dependent, modulates negatively cell migration and invasion in the MDA-MB-231 breast cancer cell line
    Buchegger, Kurt
    Viscarra, Tamara
    Ili, Carmen Gloria
    Riquelme, Ismael
    Letelier, Pablo
    Corvalan, Alejandro
    Brebi, Priscilla
    Huang, Tim Hui-Ming
    Roa, Juan Carlos
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [48] Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability
    Carolina Mathias
    Stéfanne Bortoletto
    Ariana Centa
    Heloisa Komechen
    Rubens S. Lima
    Aline S. Fonseca
    Ana Paula Sebastião
    Cícero A. Urban
    Emerson W. S. Soares
    Carolina Prando
    Bonald C. Figueiredo
    Iglenir J. Cavalli
    Luciane R. Cavalli
    Enilze M. F. S. Ribeiro
    Scientific Reports, 10
  • [49] POSITIVE MODULATION OF NATIVE GABA A RECEPTORS IN MEDULLOBLASTOMA CANCER CELLS WITH BENZODIAZEPINES INDUCES RAPID MITOCHONDRIAL FRAGMENTATION AND TP53-DEPENDENT, CELL CYCLE-INDEPENDENT APOPTOSIS
    Kallay, Laura
    Keskin, Havva
    Ross, Alexandra
    Moody, Olivia
    Cottrill, Kirsten
    Nuckols, Austin
    Li, Guanguan
    Ahmed, Taukir
    Rashid, Farjana
    Stephen, Michael
    Xu, Maxwell
    Martinson, Deborah
    Macdonald, Tobey
    Kowalski, Jeanne
    Wang, Xin
    Taylor, Michael
    Cook, James
    Jenkins, Andrew
    Krummel, Daniel Pomeranz
    Sengupta, Soma
    NEURO-ONCOLOGY, 2018, 20 : 213 - 213
  • [50] Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Benton, Christopher B.
    Class, Caleb A.
    Chien, Kelly S.
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautham
    Pemmaraju, Naveen
    Konopleva, Marina
    Soltysiak, Kelly A.
    Pierce, Sherry R.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD ADVANCES, 2020, 4 (03) : 482 - 495